Insufficient evidence exists to recommend routine screening for chronic kidney disease (CKD) in asymptomatic adults, the United States Preventive Task Force (USPSTF) has concluded.
As Virginia A. Moyer, MD, MPH, and fellow USPSTF members reported online ahead of print in Annals of Internal Medicine, evidence that routine screening of CKD improves clinical outcomes for asymptomatic adults is inadequate, and evidence on the harms of such screening is inadequate.
Convincing evidence, however, shows that medications used to treat early CKD may have adverse effects.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.